LAST PRICE - AT THE CLOSE
CURE is UP 6% since the begininning of the year
CURE is UP 3% ABOVE 20 day SMA
CURE is UP 15% ABOVE 200 day SMA
PROFITABLE: N/A
EPS: N/A
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: N/A
 |
THE STOCK IS 20.6% AWAY FROM ALL-TIME HIGHS OF $149.575 |
 |
CURE IS UP 6% SINCE THE BEGINNING OF THE YEAR |
 |
CURE IS UP 50% OVER THE PAST 12 MONTHS |
 |
CURE IS UP 17% OVER THE PAST 1 MONTH |
 |
N/A% OF ALL CURE INVESTORS ARE BETTING AGAINST CURE |
 |
NUM INVESTORS SHORT CURE HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
CURE moved down 0.32 in the previous minute |
 |
CURE is up 0.22 over the last hour |
 |
CURE is up 1% over the last 5 days |
 |
CURE is 4.5 above its 8 day SMA |
| $118.28 |   DAY |
$120.02 |
| $112.67 |  PREVIOUS DAY |
$116.81 |
| $107.59 | WEEK |
$122.30 |
| $102.79 | MONTH |
$126.70 |
| $66.00 | YEAR |
$126.70 |
CURE is mentioned N/A less than normal on 
CURE is mentioned N/A times in an average day on 
